Pinnacle Financial Group, Inc.’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$322K Hold
425
– – 0.03% 361

Other funds holding REGN

Pinnacle Financial Group, Inc.'s REGN Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. reported 425 shares of Regeneron Pharmaceuticals (REGN) worth $322K in Q3 2026. The position accounts for 0.03% of the portfolio, ranked #361.

1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 425 shares of Regeneron Pharmaceuticals worth $322K as of Q3 2026.
  • Regeneron Pharmaceuticals made up 0.03% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #361 holding.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.